Trials / Completed
CompletedNCT04847622
Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.
A Multi-centre, Multi-country Retrospective Cohort Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 451 (actual)
- Sponsor
- NEAT ID Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-centre, multi-country retrospective cohort study. At least 450COVID-19 cases from up to 20 participating study sites who meet all eligibility criteria will be included in the analysis. Deidentified data will be extracted from electronic medical record (EMR) databases, clinical registries, case series or additional sources from participating sites and countries, and then entered into a structured e-CRF system. addition, each site/country will be surveyed to determine the local standard of care therapy for COVID-19 infection and to determine if standard protocols were/are in place for the use of Remdesivir and if/how the protocols changed over time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remdesivir | treated with Remdesivir |
Timeline
- Start date
- 2021-02-12
- Primary completion
- 2021-04-30
- Completion
- 2021-04-30
- First posted
- 2021-04-19
- Last updated
- 2024-11-29
- Results posted
- 2024-11-29
Locations
12 sites across 5 countries: France, Israel, Netherlands, Spain, United Kingdom
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04847622. Inclusion in this directory is not an endorsement.